Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122326852 | 12232685 | 2 | F | 20160314 | 20160926 | 20160401 | 20160929 | EXP | US-TAKEDA-2016MPI002248 | TAKEDA | 74.62 | YR | M | Y | 0.00000 | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122326852 | 12232685 | 1 | PS | NINLARO | IXAZOMIB | 1 | Oral | 4 MG, 1/WEEK | 208462 | 4 | MG | CAPSULE | /wk | ||||||
| 122326852 | 12232685 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 4 MG, UNK | 0 | 4 | MG | ||||||||
| 122326852 | 12232685 | 3 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | U | 0 | INJECTION | ||||||||
| 122326852 | 12232685 | 4 | C | TORSEMIDE. | TORSEMIDE | 1 | Unknown | 5 MG, UNK | 0 | 5 | MG | ||||||||
| 122326852 | 12232685 | 5 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 122326852 | 12232685 | 6 | C | CARVEDILOL. | CARVEDILOL | 1 | Unknown | 6.25 MG, BID | 0 | 6.25 | MG | BID | |||||||
| 122326852 | 12232685 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 100 MG, BID | 0 | 100 | MG | BID | |||||||
| 122326852 | 12232685 | 8 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Unknown | 81 MG, QD | 0 | 81 | MG | QD | |||||||
| 122326852 | 12232685 | 9 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 200 MG, QD | 0 | 200 | MG | QD | |||||||
| 122326852 | 12232685 | 10 | C | SENOKOT | SENNOSIDES | 1 | Unknown | UNK, BID | 0 | BID | |||||||||
| 122326852 | 12232685 | 11 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | 500 MG, UNK | 0 | 500 | MG | ||||||||
| 122326852 | 12232685 | 12 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Intramuscular | 1000 ?G, MONTHLY | 0 | 1000 | UG | INJECTION | /month | ||||||
| 122326852 | 12232685 | 13 | C | VITAMIN B3 | NIACIN | 1 | Oral | UNK, QD | 0 | QD | |||||||||
| 122326852 | 12232685 | 14 | C | KCL | POTASSIUM CHLORIDE | 1 | Oral | 10 MEQ, QD | 0 | 10 | MEQ | TABLET | QD | ||||||
| 122326852 | 12232685 | 15 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 75 MG, QD | 0 | 75 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122326852 | 12232685 | 1 | Plasma cell myeloma |
| 122326852 | 12232685 | 2 | Plasma cell myeloma |
| 122326852 | 12232685 | 3 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122326852 | 12232685 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122326852 | 12232685 | Acne | |
| 122326852 | 12232685 | Coronary arterial stent insertion | |
| 122326852 | 12232685 | Dysphonia | |
| 122326852 | 12232685 | Hiccups | |
| 122326852 | 12232685 | Off label use | |
| 122326852 | 12232685 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122326852 | 12232685 | 1 | 20160307 | 0 |